Riskpilot← Back to searchSign inGet full accessGENTIAN DIAGNOSTICS ASA
ASAActiveOrg 983860516Bjørnåsveien 5, 1596 MossTechnical testing and analysis · NACE 7120Est. 20012 employeeswww.gentian.no
Revenue 2024
NOK 1,6M
EBITDA margin
-633.9%
+30% vs 2023
Equity ratio
96.7%
Financial strength
Net profit 2024
NOK -3,4M
+60% vs 2023
| Revenue | NOK 1,6M | — |
| EBITDA | NOK -10,2M | +30% |
| Net profit | NOK -3,4M | +60% |
| Total assets | NOK 260,4M | -1% |
| Equity | NOK 251,8M | -3% |
| Employees | 2 | — |
Legal name
GENTIAN DIAGNOSTICS ASA
Org number
983860516
Legal form
Allmennaksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
1. november 2001
Share capital
NOK 1 545 862
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling og markedsføring av analysesystemer for medisinsk in vitro diagnostikk og i den forbindelse salg av konsulenttjenester samt ved aksjetegning eller på annen måte å delta i andre selskaper eller andre foretagender med økonomisk formål.
Address
Bjørnåsveien 5, 1596 Moss
Website
www.gentian.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 456 | 4 040 | 0 | 1 604 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −5 186 | −13 475 | −10 955 | −14 544 | −10 168 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 186 | −13 475 | −10 955 | −14 544 | −10 168 |
| Net financials | 2 929 | 632 | 3 465 | 6 018 | 6 761 |
| Profit before tax | −2 257 | −12 843 | −7 490 | −8 526 | −3 407 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 257 | −12 843 | −7 490 | −8 526 | −3 407 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 280 758 | 273 877 | 269 370 | 262 525 | 260 391 |
| Equity | 280 676 | 272 076 | 266 329 | 260 397 | 251 813 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 82 | 1 800 | 3 041 | 2 128 | 8 578 |
| Total debt | 82 | 1 800 | 3 041 | 2 128 | 8 578 |
EBITDA margin
-633.9%
This company
15.8%
Market median
-4112% vs market
20202024
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-212.4%
This company
8.1%
Market median
-2722% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
NK Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2024 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Former (8) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2022 – 2024 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 13.68% | 13.68% | 2024 | |
| Company | 11.69% | 11.69% | 2024 | |
| Company | 7.97% | 7.97% | 2024 | |
| Individual | 7.88% | 7.88% | 2022 | |
| Company | 4.52% | 4.52% | 2024 | |
| Company | 4.21% | 4.21% | 2024 | |
| Company | 3.75% | 3.75% | 2024 | |
J.P. Morgan Se | Company | 3.4% | 3.4% | 2024 |
| Individual | 3.23% | 3.23% | 2022 | |
| Company | 2.49% | 2.49% | 2024 | |
| Company | 2.31% | 2.31% | 2024 | |
| Individual | 2.11% | 2.11% | 2022 | |
| Company | 1.95% | 1.95% | 2024 | |
| Individual | 1.93% | 1.93% | 2024 | |
| Company | 1.68% | 1.68% | 2024 | |
| Company | 1.67% | 1.67% | 2024 | |
Skandinaviska Enskilda Banken Ab | Company | 1.62% | 1.62% | 2024 |
| Company | 1.59% | 1.59% | 2022 | |
| Company | 1.52% | 1.52% | 2024 | |
| Company | 1.43% | 1.43% | 2024 | |
| Company | 1.38% | 1.38% | 2024 | |
| Company | 1.37% | 1.37% | 2024 | |
| Company | 1.36% | 1.36% | 2024 | |
| Company | 1.18% | 1.18% | 2024 | |
| Company | 1.12% | 1.12% | 2024 | |
| Company | 1.07% | 1.07% | 2024 | |
| Individual | 1.01% | 1.01% | 2022 | |
| Company | 1.01% | 1.01% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vatne Capital As
GENTIAN DIAGNOSTICS ASA Board members of GENTIAN DIAGNOSTICS ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Matti Jussi Tapio Heinonen | Chief Executive Officer | 0 companies |
| Njaal Kind | Chief Executive Officer | 0 companies |
| Espen Tidemann Jørgensen | Board of Directors | 0 companies |
| Hilja Ibert | Chairman | 0 companies |
| Kari Eian Krogstad | Board of Directors | 0 companies |
| Runar Vatne | Board of Directors | 0 companies |
| Susanne Stuffers | Board of Directors | 0 companies |
| Tomas Kramar | Board of Directors | 0 companies |
| Kjersti Grimsrud | Board of Directors | 0 companies |
| Monika Neuman | Board of Directors | 0 companies |
| Frank Frantzen | Board of Directors | 0 companies |
| Tomas Settevik | Chairman | 0 companies |
| Christian Åbyholm | Board of Directors | 0 companies |
| Ingrid Helene Teigland Akay | Board of Directors | 0 companies |
| Fredrik Thoresen | Board of Directors | 0 companies |